At U-M Health, we offer comprehensive and individualized care that utilizes the latest technologies currently available for PCI procedures. The complex coronary revascularization team specializes in evaluating and treating patients who have been told they are not candidates for stent procedures because of difficult blockages or elevated procedure risks. 

U-M Health has a dedicated team for stenting of completely blocked coronary arteries (chronic total occlusions or CTOs) that require advanced techniques and equipment with an excellent record of safety and success. Nearly all stent procedures are performed with the guidance of “intracoronary imaging” technology, which allows our doctors to visualize blood vessels from the “inside out” to tailor stent sizes for the best result. 

U-M Health specializes in treating patients with prior failed stents and applying advanced techniques and technologies to prevent repeat blockages. 

• We are one of a few hospitals in the state of Michigan utilizing a recent FDA-approved drug-coated balloon technology, which allows interventional cardiologists to perform an angioplasty and deliver a medication to the inside of the blood vessel to prevent recurrent blockages. This technology is approved for blockages that form inside prior stents and may also be helpful for blockages not appropriate for stents.
• We also have an established intracoronary brachytherapy program that offers a procedure where radiation is applied to areas of recurrent coronary blockages to keep them from recurring. 

This treatment is for patients with:

• Atherosclerosis Aortic Disease
• Angina or chest pain
• Chronic Total Occlusion
• Coronary Artery Disease 
• Heart Attack
• Heart Failure 

To make a coronary angioplasty appointment, contact us at 888-287-1082.

At U-M Health, we have numerous clinical trials that you may be eligible for. Current clinical trials related to coronary angioplasty and stenting include: 

• COSIRA-II - This trial is testing a novel device that is implanted in the heart’s venous system and may reduce symptoms for patients who have chronic chest pain from issues with coronary blood flow that cannot otherwise be treated.
• PREVAIL Global - This trial is systematically testing drug-coated balloons (angioplasty balloons capable of delivering medicine to the blood vessel wall to prevent recurrent blockages) for patients whose vessels already have stents or are not appropriate for stents.